Skip to search formSkip to main contentSkip to account menu

HDAC Inhibitor SHP-141

Known as: SHP-141 
A topical formulation containing the histone deacetylase (HDAC) inhibitor with potential antineoplastic activity. Upon cutaneous administration, SHP… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A phase 2 randomized study of SHAPE Gel (SHP-141) in patients with early-stage cutaneous T-cell lymphoma: Interim results.
7562Background: Cutaneous T-cell lymphoma (CTCL) is a form of extranodal lymphoma where malignant T-cells infiltrate the skin… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)